Skip to main content
logo
Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ: ELOX · Real-Time Price · USD
13.98
-0.02 (-0.14%)
At close: Jun 18, 2026, 4:00 PM EDT
13.60
-0.38 (-2.72%)
After-hours: Jun 18, 2026, 6:47 PM EDT

Eloxx Pharmaceuticals Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
10
Market Cap
56.43M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 20246.36M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Jun 30, 201675.00K--
Dec 31, 2015---
Jun 30, 201575.00K--
Dec 31, 2014---
Jun 30, 2014100.00K--
Jun 30, 2013---
Jun 30, 2012200.00K--
Jun 30, 2011---
Jun 30, 2010140.00K-135.00K-49.09%
Jun 30, 2009275.00K-181.67K-39.78%
Jun 30, 2008456.67K156.67K52.22%
Jun 30, 2007300.00K233.33K350.00%
Jun 30, 200666.67K-58.33K-46.67%
Jun 30, 2005125.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Xilio Therapeutics53.48M
TScan Therapeutics9.14M
Immutep5.28M
iBio, Inc.300.00K
Entera Bio42.00K
Impact BioMedical39.00K
Revenue Rankings

ELOX News

More News